REGISTERED NUMBER: 09865411 (England and Wales)

FINANCIAL STATEMENTS FOR THE PERIOD 1 NOVEMBER 2024 TO 31 MARCH 2026

FOR

PRIME MEDICAL CONSULTING LIMITED

Page

Company Information

1

Balance Sheet

2

DIRECTOR:

Dr Y M M Mukhtar

REGISTERED OFFICE:

27 Wilcot Avenue

Watford

Hertfordshire

WD19 4AT

REGISTERED NUMBER:

09865411 (England and Wales)

ACCOUNTANTS:

Auctus Accountants Ltd

2 Churchill Court

58 Station Road

Harrow

Middlesex

HA2 7SA

FIXED ASSETS

1,066,073

50,375

CURRENT ASSETS

552,222

1,144,122

CREDITORS

Amounts falling due within one year

(154,318

)

(153,399

)

NET CURRENT ASSETS

397,904

990,723

TOTAL ASSETS LESS CURRENT LIABILITIES

1,463,977

1,041,098

CAPITAL AND RESERVES

1,463,977

1,041,098

NOTES TO THE FINANCIAL STATEMENTS

1.	AVERAGE NUMBER OF EMPLOYEES

The average number of employees during the period was 1 (2024 - 1 ) .

2.	DIRECTOR'S ADVANCES, CREDITS AND GUARANTEES

Included in the debtors is loan to director of £52,478 (2024 -Nil) which has been repaid after the year end.Interest has been charged on the loan.

The company is entitled to exemption from audit under Section 477 of the Companies Act 2006 for the period ended 31 March 2026.

The members have not required the company to obtain an audit of its financial statements for the period ended 31 March 2026 in accordance with Section 476 of the Companies Act 2006.

The director acknowledges his responsibilities for:

(a)	ensuring that the company keeps accounting records which comply with Sections 386 and 387 of the Companies Act 2006 and

(b)

preparing financial statements which give a true and fair view of the state of affairs of the company as at the end of each financial year and of its profit or loss for each financial year in accordance with the requirements of Sections 394 and 395 and which otherwise comply with the requirements of the Companies Act 2006 relating to financial statements, so far as applicable to the company.

The financial statements have been prepared in accordance with the micro-entity provisions and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

The financial statements were approved by the director and authorised for issue on 29 October 2026 and were signed by:

Dr Y M M Mukhtar - Director